The article discusses the trends in the pharmaceutical market and possible trends in the level of salaries specialist registration in 2016 .The review will primarily be of interest to applicants to the post.the Economic situation in Russia remains intense and, according to the government of the Russian Federation, in the near future positive changes should be expected. The decline of the national currency and Western sanctions have a negative impact on investment attractiveness. A number of companies such as Mead Johnson, left the Russian market. Others cut staff massively. Those businesses that escaped large cuts, reducing the budget for recruitment of new specialists (GlaxoSmithKline). Such tendencies cannot but frighten the employees in almost all business areas including pharmaceutical industry. What has changed for employees of the back office of the farm business this year and what changes should wait for the experts next? Consider the example of employees of the Department of registration.
first, it should be understood that for specialists in the back office of the General economic situation has had less influence than «veterans» (medical representatives and their direct supervisors). Sales professionals are also more susceptible to reductions, the revision of bonus schemes and targets during the crisis period. At the time, as managers don’t have, as a rule, strict targets. Moreover, the demand of these specialists depends on the number of medications (or medical products) which are in the process of registration. The number of drugs in turn, depends on the development of new molecules (for companies-originators), the number ended on the expiration of patents (for generic companies).
In 2015, the year in pharmaceutical companies have not achieved significant reductions specialists in registration. On the contrary, the growth rate of wages, though considerably decreased, but continued. What to expect specialists next year? For this purpose it is necessary to learn the latest news of pharmaceutical industry of Russia.
this year, contrary to the General trends in the national economy, the pharmaceutical industry, despite a number of losses and cuts, has demonstrated generally positive dynamics. It is no accident the Deputy Minister of industry and trade of the Russian Federation Sergey Tsyb has described the market as «investment boom». Thus, the volume of investments into the pharmaceutical sector private foreign and domestic companies amounted to over 120 billion rubles. Over the last three years in Russia introduced more than 10 new pharmaceutical plants, including with participation of foreign capital. A large-scale modernization of existing facilities and development of Russian producers of new competences and new knowledge in the field of production.
Moreover, this year the FCS has simplified the rules for the import and registration of imported pharmaceuticals. This, in turn, stimulates foreign companies to bring new products to the Russian market. For example, Merck announced a new strategy of development of sales in the Russian region, which is aimed at increasing technology transfer company for the development of sales. Moreover, there is a growing market of drugs for HIV/AIDS, which also require registration.
All of this suggests that managers expect a hot reception. At the moment at various stages of registration is about 130 drugs. In connection with the simplification of procedure at the legislative level – the number will increase even more. This means that to worry about mass reduction specialists is not worth it. And whether the wage growth of a significant – time will tell.
Eugene DOB
Consultant recruitment
Recruitment company AVICONN